Biotinylated SARS-CoV-2 Nucleocapsid Protein


Catalog Number: B2010502 (25 ug)
Biotinylated SARS-CoV-2 Nucleocapsid Protein is a highly pure biotinylated recombinant SARS-CoV-2 Nucleocapsid Protein expressed in Baculovirus Insect Cells. This product has been used as molecular component of serological and antigenic assays for SARS-CoV-2. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request.

Live enquiry about this product via Text/SMS: 1-858-900-3210.

In stock

SKU: B2010502 Categories: , Tag:


Biotinylated SARS-CoV-2 Nucleocapsid Protein
Catalog number: B2010502
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: 47 kDa
Supplied as: Liquid Solution
Applications: molecular component of serological and antigenic assays for SARS-CoV-2
Storage: -20℃
Keywords: Nucleoprotein, N protein, biotin-nucleoprotein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

Download SARS-CoV-2 Brochure

1: Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020

2: Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi
PY. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020 Oct

3: Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, Pan P, Wu K, Wu J. SARS-CoV-2
Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β
Production. Viruses. 2020 Dec 30;13(1):47.

4: Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential
Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV
Immunological Studies. Viruses. 2020 Feb 25;12(3):254.

5: Mu J, Xu J, Zhang L, Shu T, Wu D, Huang M, Ren Y, Li X, Geng Q, Xu Y, Qiu Y,
Zhou X. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of
RNA interference in cells. Sci China Life Sci. 2020 Sep;63(9):1413-1416.

6: Dutta NK, Mazumdar K, Gordy JT. The Nucleocapsid Protein of SARS-CoV-2: a
Target for Vaccine Development. J Virol. 2020 Jun 16;94(13):e00647-20.

7: Oliveira SC, de Magalhães MTQ, Homan EJ. Immunoinformatic Analysis of SARS-
CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Front
Immunol. 2020 Oct 28;11:587615.

8: Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X,
Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen RA, Wu YJ, Peng SM, Huang M, Xie
WJ, Cai QH, Hou FH, Chen W, Xiao L, Shen Y. Isolation of SARS-CoV-2-related
coronavirus from Malayan pangolins. Nature. 2020 Jul;583(7815):286-289.

9: Li JY, Liao CH, Wang Q, Tan YJ, Luo R, Qiu Y, Ge XY. The ORF6, ORF8 and
nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
Virus Res. 2020 Sep;286:198074.
10: Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the
pandemic coronavirus: Molecular and structural insights. J Basic Microbiol. 2021

Products Related to Biotinylated SARS-CoV-2 Nucleocapsid Protein : SARS-CoV-2

Ordering Information

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: (we accept electronic PO, available 24/7).

3- Order by Fax: 1-858-437-9884 (available 24/7).

4- Order by phone: 1-858-900-3210 (6 am – 8 pm PST).

5- Order by Text/SMS: 1-858-900-3210 (6 am – 8 pm PST).